We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2059:TWSEKing Slide Works Co., Ltd. Analysis

Data as of 2026-03-11 - not real-time

NT$3,355.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

King Slide Works is delivering exceptional profitability, with a 59.7% revenue growth rate and gross, operating and profit margins of 76%, 69% and 56% respectively, while generating a ROE of nearly 40% and a free cash flow of TWD 7.76 bn. Its balance sheet is solid, boasting over TWD 24 bn in cash against modest debt, and a dividend payout ratio of just 32%, indicating that the 1.05% yield is sustainable.
Technically, the stock trades at TWD 3,355, comfortably above its 20‑day (TWD 3,143) and 200‑day (TWD 3,069) moving averages and just above the 50‑day average (TWD 3,337), with a bullish MACD histogram (+15.7) and an RSI of 54, suggesting room for upside before hitting the resistance level of TWD 3,540. The DCF‑derived fair value (TWD 3,346) aligns closely with the market price, while a forward PE of 19× versus a trailing PE of 33× signals that earnings are expected to accelerate, supporting the analysts’ strong‑buy consensus and a median target of TWD 4,750.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and price above key moving averages
  • Strong support at TWD 2,875 and stable volume
  • Momentum still below resistance, offering upside potential

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust 60% revenue growth and high operating margins
  • Forward PE compression to 19× indicating earnings acceleration
  • Analyst consensus of strong‑buy with median target near TWD 4,750

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend backed by ample cash and low payout ratio
  • Consistently high ROE and ROA reflecting durable competitive advantage
  • Long‑term industry tailwinds in data‑center and furniture solutions

Key Metrics & Analysis

Financial Health

Revenue Growth59.70%
Profit Margin56.21%
P/E Ratio33.3
ROE39.89%
ROA24.55%
Debt/Equity5.88
P/B Ratio11.4
Op. Cash FlowNT$11.3B
Free Cash FlowNT$7.8B

Technical Analysis

TrendNeutral
RSI54.2
SupportNT$2,875.00
ResistanceNT$3,540.00
MA 20NT$3,143.25
MA 50NT$3,337.30
MA 200NT$3,068.85
MACDBullish
VolumeStable
Fear & Greed Index78.13

Valuation

Fair ValueNT$3,345.86
Target PriceNT$4,594.25
Upside/Downside36.94%
GradeUndervalued
TypeGrowth
Dividend Yield1.05%

Risk Assessment

Beta0.81
Volatility63.06%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.